Jazz Pharmaceuticals Inc.
Company Snapshot
Founded: 2003
Entity Type: Public
Employees: 2,890
Region: U.S.
Revenue: $4,267.6 Millions
Revenue Year: 2025
Segment: Oncology and Neuroscience
Headquarter: Dublin, Ireland
Key Geographics: U.S., Europe, Other Countries
Corporate Address: Waterloo Exchange Waterloo Road Dublin 4 Ireland Tel. +353-1-634-7800 www.jazzpharma.com
Company Overview
Jazz Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing innovative medicines for serious diseases, particularly those with limited treatment options. Its portfolio includes sleep disorders, epilepsy, and cancer treatments. Focusing on patient outcomes and clinical rigor, we are developing a diverse pipeline of innovative therapies in oncology and beyond neuroscience.
Jazz Pharmaceuticals operates in two business segments – Neuroscience and Oncology. There are 2,800 employees as of December 31, 2024, and it has a prominent presence in the U.S., Europe, and around seventy-five countries.
Financial Highlights (FY 2025)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Jazz Pharmaceuticals Inc. In Reports
Jazz Pharmaceuticals Inc. In News
Company's Business Segments
- Oncology and Neuroscience : The company develops and commercializes medicines, particularly for narcolepsy, cancer, pain, and psychiatry, focusing on unmet medical needs.
Applications/End User Industries
- Healthcare
- Biopharmaceutical
- Life Sciences
- Oncology
- Neuroscience